Eplontersen for Transthyretin Amyloid Cardiomyopathy
New England Journal of Medicine · 28.08.2026
DOI: 10.1056/nejmoa2608510 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, online erschienen am 28.08.2026. Verfasst von Marianna Fontana und 25 weiteren Autor:innen. Beteiligte Einrichtung: National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Ionis Pharmaceuticals, AstraZeneca.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London.
- Division of Cardiovascular Medicine, Oregon Health and Sciences University, Portland.
- Cardiovascular Division, Brigham and Women's Hospital, Boston.
- Tuscan Regional Amyloidosis Center, Department of Clinical and Experimental Medicine, Careggi University Hospital, Florence, Italy.
- Division of Cardiology, University of British Columbia, Vancouver, Canada.
- Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro, Madrid.
ORCID-Profile: Marianna Fontana, Scott D Solomon, Julian D Gillmore, Nobuhiro Tahara, Olga Azevedo, Mathew S Maurer
Förderung
- Ionis Pharmaceuticals
- AstraZeneca
Zitieren
APA
Fontana, M., Masri, A., Solomon, S. D., Cappelli, F., Davis, M. K., García-Pavía, P., Gillmore, J. D., Hanna, M., Obici, L., Sperry, B. W., Tahara, N., Waddington-Cruz, M., Azevedo, O., Damy, T., de Barros Correia, E., Khouri, M. G., Nikolova, A. P., Störk, S., Conrad, T., …, & CARDIO-TTRansform Investigators (2026). Eplontersen for Transthyretin Amyloid Cardiomyopathy. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2608510
Vancouver
Fontana M, Masri A, Solomon SD, Cappelli F, Davis MK, García-Pavía P, et al. Eplontersen for Transthyretin Amyloid Cardiomyopathy. New England Journal of Medicine. 2026. doi:10.1056/nejmoa2608510
BibTeX
@article{Fontana2026,
author = {Fontana, Marianna and Masri, Ahmad and Solomon, Scott D and Cappelli, Francesco and Davis, Margot K and García-Pavía, Pablo and Gillmore, Julian D and Hanna, Mazen and Obici, Laura and Sperry, Brett W and Tahara, Nobuhiro and Waddington-Cruz, Márcia and Azevedo, Olga and Damy, Thibaud and de Barros Correia, Edileide and Khouri, Michel G and Nikolova, Andriana P and Störk, Stefan and Conrad, Tom and Yang, Qingqing and Claggett, Brian L and Chen, Jersey and Brice, Gary T and Tsimikas, Sotirios and Maurer, Mathew S and CARDIO-TTRansform Investigators, CARDIO-TTRansform Investigators},
title = {Eplontersen for Transthyretin Amyloid Cardiomyopathy},
journal = {New England Journal of Medicine},
year = {2026},
doi = {10.1056/nejmoa2608510}
}
EUVIMED